Centessa Pharmaceuticals (CNTA) Debt to Equity (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Debt to Equity of $0.23 for Q1 2026, down 19.88% year-over-year from $0.28 in Q1 2025, and up 8.45% quarter-over-quarter from $0.21 in Q4 2025.
Centessa Pharmaceuticals (CNTA) Debt to Equity (2020 - 2026) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 7 years of Debt to Equity data on file, last reported at $0.23 in Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.23, down 19.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.23 (down 19.88% YoY), and the FY2025 annual result was $0.21, down 22.98% from the prior year.
- Debt to Equity improved to $0.23 in Q1 2026 per CNTA's latest filing, from $0.21 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.36 in Q3 2025 and troughed at $0.15 in Q3 2024.
- A 5-year average of $0.25 and a median of $0.26 in 2023 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2024 and 2025: Debt to Equity sank 46.84% in 2024, then soared 140.1% in 2025.
- A 5-year view of Debt to Equity shows it stood at $0.21 in 2022, then soared by 54.33% to $0.32 in 2023, then slipped by 15.33% to $0.27 in 2024, then dropped by 22.98% to $0.21 in 2025, then gained by 8.45% to $0.23 in 2026.
- Business Quant data shows CNTA's Debt to Equity at $0.23 in Q1 2026, $0.21 in Q4 2025, and $0.36 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Centessa Pharmaceuticals | 6.10 Bn | 6.10 Bn | - | 0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | 0.21 |
| Sep 30, 2025 | 0.36 |
| Jun 30, 2025 | 0.32 |
| Mar 31, 2025 | 0.28 |
| Dec 31, 2024 | 0.27 |
| Sep 30, 2024 | 0.15 |
| Jun 30, 2024 | 0.27 |
| Mar 31, 2024 | 0.36 |
| Dec 31, 2023 | 0.32 |
| Sep 30, 2023 | 0.29 |
| Jun 30, 2023 | 0.26 |
| Mar 31, 2023 | 0.24 |
| Dec 31, 2022 | 0.21 |
| Sep 30, 2022 | 0.18 |
| Jun 30, 2022 | 0.16 |
| Mar 31, 2022 | 0.16 |
| Dec 31, 2021 | 0.15 |
| Dec 31, 2020 | -0.04 |